RenaissanceRe Ltd. (RNR) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    RenaissanceRe Ltd.

    NYSE: RNR · Real-Time Price · USD
    250.80
    3.35 (1.35%)
    At close: Sep 26, 2025, 3:59 PM
    250.61
    -0.08%
    After-hours: Sep 26, 2025, 06:24 PM EDT

    RenaissanceRe Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 11.65B 9.09B 5.05B 5.27B
    Cost of Revenue
    		 7.98B n/a 5.91B 5.09B
    Gross Profit
    		 3.67B 9.09B 5.12B 174.46M
    Operating Income
    		 3.04B 3.14B -1.18B -76.58M
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 2.99B 3.11B -1.22B -114.11M
    Net Income
    		 1.87B 2.53B -1.06B -40.88M
    Selling & General & Admin
    		 n/a 426.42M 323.47M 253.34M
    Research & Development
    		 n/a n/a n/a n/a
    Other Expenses
    		 631.37M n/a 37.09M n/a
    Operating Expenses
    		 631.37M 426.42M 360.55M 253.34M
    Interest Expense
    		 93.77M 73.18M 48.34M 47.54M
    Selling & Marketing Expenses
    		 n/a 375.18M n/a n/a
    Cost & Expenses
    		 8.61B 5.98B 6.23B 5.38B
    Income Tax Expense
    		 32.63M -510.07M -59.02M -10.67M
    Shares Outstanding (Basic)
    		 51.19M 47.49M 43.04M 47.17M
    Shares Outstanding (Diluted)
    		 51.34M 47.61M 43.04M 47.17M
    EPS (Basic)
    		 35.31 52.40 -25.5 -1.57
    EPS (Diluted)
    		 35.21 52.27 -25.5 -1.57
    EBITDA
    		 3.01B 3.28B -1.2B -126.27M
    EBIT
    		 3.09B 3.14B -1.17B -105.28M
    Depreciation & Amortization
    		 -76.08M 134.75M -26.95M -20.99M

    Add to Watchlist